These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26325308)

  • 1. Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase.
    Peters E; Stevens J; Arend J; Guan Z; Raaben W; Laverman P; Elsas AV; Masereeuw R; Pickkers P
    Int J Pharm; 2015 Nov; 495(1):122-131. PubMed ID: 26325308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.
    Peters E; Heuberger JAAC; Tiessen R; van Elsas A; Masereeuw R; Arend J; Stevens J; Pickkers P
    Clin Pharmacokinet; 2016 Oct; 55(10):1227-1237. PubMed ID: 27147514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury.
    Peters E; Ergin B; Kandil A; Gurel-Gurevin E; van Elsas A; Masereeuw R; Pickkers P; Ince C
    Toxicol Appl Pharmacol; 2016 Dec; 313():88-96. PubMed ID: 27760303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate.
    Peters E; Geraci S; Heemskerk S; Wilmer MJ; Bilos A; Kraenzlin B; Gretz N; Pickkers P; Masereeuw R
    Br J Pharmacol; 2015 Oct; 172(20):4932-45. PubMed ID: 26222228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans.
    Tunjungputri RN; Peters E; van der Ven A; de Groot PG; de Mast Q; Pickkers P
    Thromb Haemost; 2016 Nov; 116(6):1111-1121. PubMed ID: 27656709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
    Peters E; Mehta RL; Murray PT; Hummel J; Joannidis M; Kellum JA; Arend J; Pickkers P
    BMJ Open; 2016 Sep; 6(9):e012371. PubMed ID: 27678541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells.
    Peters E; Schirris T; van Asbeck AH; Gerretsen J; Eymael J; Ashikov A; Adjobo-Hermans MJ; Russel F; Pickkers P; Masereeuw R
    Eur J Pharmacol; 2017 Feb; 796():149-157. PubMed ID: 28012971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure.
    Engelmann C; Adebayo D; Oria M; De Chiara F; Novelli S; Habtesion A; Davies N; Andreola F; Jalan R
    Sci Rep; 2020 Jan; 10(1):389. PubMed ID: 31942020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
    Peters E; Masereeuw R; Pickkers P
    Nephron Clin Pract; 2014; 127(1-4):144-8. PubMed ID: 25343839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of minipigs for predicting human pharmacokinetics: Prediction of distribution volume and plasma clearance.
    Yoshimatsu H; Konno Y; Ishii K; Satsukawa M; Yamashita S
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):73-81. PubMed ID: 26776246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.
    Chang CH; Chou TK; Yang CY; Chang TJ; Wu YH; Lee TW
    In Vivo; 2008; 22(6):693-7. PubMed ID: 19180993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets.
    Beumer C; Wulferink M; Raaben W; Fiechter D; Brands R; Seinen W
    J Pharmacol Exp Ther; 2003 Nov; 307(2):737-44. PubMed ID: 12970380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury.
    Peters E; van Elsas A; Heemskerk S; Jonk L; van der Hoeven J; Arend J; Masereeuw R; Pickkers P
    J Pharmacol Exp Ther; 2013 Jan; 344(1):2-7. PubMed ID: 23131595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor.
    Titze MI; Schaaf O; Hofmann MH; Sanderson MP; Zahn SK; Quant J; Lehr T
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):545-558. PubMed ID: 28243682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetic-Toxicodynamic Modeling and Simulation of Cisplatin-Induced Acute Renal Injury in Rats: Effect of Dosing Rate on Nephrotoxicity.
    Fukushima K; Okada A; Sasaki K; Kishimoto S; Fukushima S; Hamori M; Nishimura A; Shibata N; Shirai T; Terauchi R; Kubo T; Sugioka N
    J Pharm Sci; 2016 Jan; 105(1):324-32. PubMed ID: 26852862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis.
    Rachmawati H; Beljaars L; Reker-Smit C; Van Loenen-Weemaes AM; Hagens WI; Meijer DK; Poelstra K
    Pharm Res; 2004 Nov; 21(11):2072-8. PubMed ID: 15587930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.
    Sands H; Li J; Duggaraju R; Kolan HR; Donegan M; Elove GA; Thakur ML
    Drug Metab Dispos; 1997 May; 25(5):631-6. PubMed ID: 9152604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
    Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients.
    Peters E; Heemskerk S; Masereeuw R; Pickkers P
    Am J Kidney Dis; 2014 Jun; 63(6):1038-48. PubMed ID: 24462020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.